Agilent Technologies Inc. Showcases New Solutions At Biopharmaceutical Symposium

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is showcasing innovative new technology this week designed to help scientists achieve the reproducible results they need to develop effective biopharmaceuticals.

The company is demonstrating its new line of AdvanceBio SEC columns at the 20th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products (Twitter hashtag #WCBP2016) today through Jan. 28 at the Mayflower Hotel in Washington, D.C.

Back to news